Literature DB >> 33552733

Physical activity modulates mononuclear phagocytes in mammary tissue and inhibits tumor growth in mice.

Donald M Lamkin1,2,3, Karen P Bradshaw1,4, Janice Chang1, Ma'ayan Epstein1, Jack Gomberg1, Krupa P Prajapati1, Veronica H Soliman1, Thezia Sylviana1, Yinnie Wong1, Kouki Morizono5,6, Erica K Sloan1,3,7,8, Steve W Cole1,2,3,5.   

Abstract

The risk for breast cancer is significantly reduced in persons who engage in greater amounts of physical activity, and greater physical activity before or after diagnosis associates with reduced disease-specific mortality. Previous mechanistic studies indicate that components of innate immunity can mediate an inhibitory effect of physical activity on several types of tumor. However, in breast cancer specifically, the myeloid compartment of innate immunity is thought to exhibit high propensity for an immunosuppressive role that obstructs anti-tumor immunity. Thus, we tested the notion that greater physical activity alters mononuclear phagocytes in mammary tissue when inhibiting nascent tumor in a murine model of breast cancer. To model greater physical activity, we placed an angled running wheel in each mouse's home cage for two weeks before tumor engraftment with EO771 mammary cancer cells that express luciferase for bioluminescent detection. Fully immunocompetent mice and mice with compromised adaptive immunity showed significantly less mammary tumor signal when given access to running wheels, although the effect size was smaller in this latter group. To investigate the role of the myeloid compartment, mononuclear phagocytes were ablated by systemic injection of clodronate liposomes at 24 h before tumor engraftment and again at the time of tumor engraftment, and this treatment reversed the inhibition in wheel running mice. However, clodronate also inhibited mammary tumor signal in sedentary mice, in conjunction with an expected decrease in gene and protein expression of the myeloid antigen, F4/80 (Adgre1), in mammary tissue. Whole transcriptome digital cytometry with CIBERSORTx was used to analyze myeloid cell populations in mammary tissue following voluntary wheel running and clodronate treatment, and this approach found significant changes in macrophage and monocyte populations. In exploratory analyses, whole transcriptome composite scores for monocytic myeloid-derived suppressor cell (M-MDSC), macrophage lactate timer, and inflammation resolution gene expression programs were significantly altered. Altogether, the results support the hypothesis that physical activity inhibits nascent mammary tumor growth by enhancing the anti-tumor potential of mononuclear phagocytes in mammary tissue. ©2021 Lamkin et al.

Entities:  

Keywords:  Breast cancer; Exercise oncology; Innate immunity; Macrophages; Monocytes; Myeloid cells; Transcriptomics; Tumor immunology; Voluntary wheel running

Year:  2021        PMID: 33552733      PMCID: PMC7821756          DOI: 10.7717/peerj.10725

Source DB:  PubMed          Journal:  PeerJ        ISSN: 2167-8359            Impact factor:   2.984


  65 in total

1.  Standardized single-platform assay for human monocyte subpopulations: Lower CD14+CD16++ monocytes in females.

Authors:  Irene Heimbeck; Thomas P J Hofer; Christiane Eder; Adam K Wright; Marion Frankenberger; Ayman Marei; Ghada Boghdadi; Jürgen Scherberich; Loems Ziegler-Heitbrock
Journal:  Cytometry A       Date:  2010-09       Impact factor: 4.355

2.  Selective mobilization of CD14(+)CD16(+) monocytes by exercise.

Authors:  B Steppich; F Dayyani; R Gruber; R Lorenz; M Mack; H W Ziegler-Heitbrock
Journal:  Am J Physiol Cell Physiol       Date:  2000-09       Impact factor: 4.249

3.  High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.

Authors:  Carsten Krieg; Malgorzata Nowicka; Silvia Guglietta; Sabrina Schindler; Felix J Hartmann; Lukas M Weber; Reinhard Dummer; Mark D Robinson; Mitchell P Levesque; Burkhard Becher
Journal:  Nat Med       Date:  2018-01-08       Impact factor: 87.241

4.  Exercise effects on polyp burden and immune markers in the ApcMin/+ mouse model of intestinal tumorigenesis.

Authors:  Jamie L McClellan; Jennifer L Steiner; Stani D Day; Reilly T Enos; Mark J Davis; Udai P Singh; E Angela Murphy
Journal:  Int J Oncol       Date:  2014-05-22       Impact factor: 5.650

5.  Determining cell type abundance and expression from bulk tissues with digital cytometry.

Authors:  Aaron M Newman; Chloé B Steen; Chih Long Liu; Andrew J Gentles; Aadel A Chaudhuri; Florian Scherer; Michael S Khodadoust; Mohammad S Esfahani; Bogdan A Luca; David Steiner; Maximilian Diehn; Ash A Alizadeh
Journal:  Nat Biotechnol       Date:  2019-05-06       Impact factor: 54.908

Review 6.  Monocyte heterogeneity and functions in cancer.

Authors:  Claire E Olingy; Huy Q Dinh; Catherine C Hedrick
Journal:  J Leukoc Biol       Date:  2019-02-18       Impact factor: 4.962

7.  Metabolic regulation of gene expression by histone lactylation.

Authors:  Di Zhang; Zhanyun Tang; He Huang; Guolin Zhou; Chang Cui; Yejing Weng; Wenchao Liu; Sunjoo Kim; Sangkyu Lee; Mathew Perez-Neut; Jun Ding; Daniel Czyz; Rong Hu; Zhen Ye; Maomao He; Y George Zheng; Howard A Shuman; Lunzhi Dai; Bing Ren; Robert G Roeder; Lev Becker; Yingming Zhao
Journal:  Nature       Date:  2019-10-23       Impact factor: 49.962

Review 8.  Resolution of inflammation: an integrated view.

Authors:  Almudena Ortega-Gómez; Mauro Perretti; Oliver Soehnlein
Journal:  EMBO Mol Med       Date:  2013-04-17       Impact factor: 12.137

9.  Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics.

Authors:  Hamad Alshetaiwi; Nicholas Pervolarakis; Laura Lynn McIntyre; Dennis Ma; Quy Nguyen; Jan Akara Rath; Kevin Nee; Grace Hernandez; Katrina Evans; Leona Torosian; Anushka Silva; Craig Walsh; Kai Kessenbrock
Journal:  Sci Immunol       Date:  2020-02-21

10.  Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study.

Authors:  Luc Y Dirix; Istvan Takacs; Guy Jerusalem; Petros Nikolinakos; Hendrik-Tobias Arkenau; Andres Forero-Torres; Ralph Boccia; Marc E Lippman; Robert Somer; Martin Smakal; Leisha A Emens; Borys Hrinczenko; William Edenfield; Jayne Gurtler; Anja von Heydebreck; Hans Juergen Grote; Kevin Chin; Erika P Hamilton
Journal:  Breast Cancer Res Treat       Date:  2017-10-23       Impact factor: 4.872

View more
  1 in total

1.  Sanguinarine Regulates Tumor-Associated Macrophages to Prevent Lung Cancer Angiogenesis Through the WNT/β-Catenin Pathway.

Authors:  Yajing Cui; Yingbin Luo; Qiaohong Qian; Jianhui Tian; Zhihong Fang; Xi Wang; Yaoying Zeng; Jianchun Wu; Yan Li
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.